Kardium

Services

Kardium specializes in developing advanced medical devices for the treatment of atrial fibrillation. Its primary offering, the Globe Pulsed Field System, provides a comprehensive solution that includes single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation. This system is designed to enhance the accuracy and effectiveness of catheter ablation procedures.

Products

Kardium's flagship product is the Globe Pulsed Field System. This innovative device features a catheter with 122 electrodes, enabling single-shot pulmonary vein isolation and high-definition mapping. The system is engineered to facilitate atrial ablation and improve procedural outcomes for patients undergoing treatment for atrial fibrillation.

Sector

Kardium operates within the medical technology sector, focusing primarily on solutions for cardiac health. Its Globe Pulsed Field System is intended for use in the catheter ablation market, which is valued at approximately $6 billion. The company's technology aims to provide enhanced treatment options for atrial fibrillation, a common cardiac rhythm disorder.

History

Headquartered in Burnaby, BC, Canada, with a European office in Schwerte, Germany, Kardium has established itself as a leader in medical technology. The company has garnered recognition, being named Medical Technology Company of the Year in 2015 and 2021 by LifeSciences BC. Kardium's portfolio includes over 100 patents related to its Globe Pulsed Field Mapping and Ablation System, underscoring its commitment to innovation.

Report inaccurate information

Companies similar to Kardium

Acutus Medical, founded in 2011 and based in San Diego, CA, specializes in advanced cardiac mapping and ablation technologies, including the AcQMap System and AcQBlate FORCE Sensing Ablation Catheter, to support personalized arrhythmia treatment.

Corveus Medical, based in Houston, TX, specializes in developing catheter-based devices for targeted nerve ablation to treat chronic heart failure, focusing on minimizing collateral tissue damage.

Profound Medical develops advanced, incision-free therapies using real-time MRI and thermal ultrasound for tissue ablation, offering technologies like TULSA-PRO® and Sonalleve®.

Imricor, founded in 2006, specializes in developing MRI-compatible technology for cardiac procedures, including the Vision-MR Ablation Catheter and the Advantage-MR EP Recorder/Stimulator.

Dilon Technologies specializes in developing and manufacturing medical devices, including the MarginProbe for breast cancer surgery and HEMOBLAST Bellows for surgical hemostasis, aimed at improving clinical outcomes primarily in women's healthcare and biosurgery.

CardioFocus provides electrophysiologists with innovative tools for the treatment of atrial fibrillation, featuring advanced laser technology and customized PFA waveform design for precise and effective procedures.

AMT Surgical, incorporated in 1992, is the largest Canadian distributor of Electrosurgical accessories, serving over 400 hospitals with a focus on innovative surgical solutions across multiple specialties.

Vena Medical, based in Kitchener, ON, Canada, is a medical device company specializing in innovative healthcare technologies, with significant achievements including FDA clearance and Health Canada approval.

Icentia is a Canadian company that designs and manufactures medical testing innovations, including the FDA-cleared CardioSTAT ECG recorder, which has been prescribed to over 170,000 patients.

AtriCure specializes in medical devices for atrial fibrillation and related conditions, offering innovative solutions like the Isolator® Synergy™ Ablation System and AtriClip® devices, with a global presence and a strong focus on clinical science and education.